Cargando…
CRISPR/Cas9: implication for modeling and therapy of amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a deadly neurological disease with a complicated and variable pathophysiology yet to be fully understood. There is currently no effective treatment available to either slow or terminate it. However, recent advances in ALS genomics have linked genes to phenotype...
Autores principales: | Shi, Yajun, Zhao, Yan, Lu, Likui, Gao, Qinqin, Yu, Dongyi, Sun, Miao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359984/ https://www.ncbi.nlm.nih.gov/pubmed/37483353 http://dx.doi.org/10.3389/fnins.2023.1223777 |
Ejemplares similares
-
Application of CRISPR/Cas9 in Alzheimer’s Disease
por: Lu, Likui, et al.
Publicado: (2021) -
CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
por: Kruminis-Kaszkiel, Ewa, et al.
Publicado: (2018) -
Development of CRISPR Cas9, spin-off technologies and their application in model construction and potential therapeutic methods of Parkinson’s disease
por: Qu, Jiangbo, et al.
Publicado: (2023) -
CRISPR/Cas9: Implications for Modeling and Therapy of Neurodegenerative Diseases
por: Yang, Weili, et al.
Publicado: (2016) -
CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs
por: Wang, Lixia, et al.
Publicado: (2017)